Pluristem Therapeutics Inc. (PSTI): Celgene’s And Osiris’ IP Positions … – Seeking Alpha
|
Pluristem Therapeutics Inc. (PSTI): Celgene’s And Osiris’ IP Positions …
Seeking Alpha In 2002, Celgene purchased Anthrogenesis, a New Jersey company banking cord blood that developed a way to recover stem cells from placental tissue. Renamed Celgene Cellular Therapeutics, this subsidiary is now conducting a Phase I, multicenter … |



